INO Financial Facts
Loss from operations: -20.2MLoss from investment in affiliated entity: -958.14K
See Full Income Statement
Total stockholders' equity: 146.98M
Accumulated other comprehensive income: 2.66M
See Full Balance Sheet
Inovio Pharma (INO) Earnings
|
Expand Research on INO
| Next EPS Date | 5/8/24 | EPS Growth Rate | -625.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +55.3% | Revenue Growth Rate | +490.9% |
| Average % Move 1-Wk after EPS | -0.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/15  |
 |
Q215 | -$0.09 | -$0.13 | +$0.04 | $5.3M | $5.52M | N/A |  | | Details |
| 8/9/22 | Q222 | -$0.39 | -$0.30 | -$0.09 | $272.82K | $529K | N/A | | | Details | |
| 3/16/15 |
|
Q414 | -$0.12 | -$0.10 | -$0.02 | $2.5M | $5.24M | N/A | | | Details |
| 11/9/16 |
|
Q316 | -$0.28 | -$0.26 | -$0.02 | $12.54M | $5.16M | N/A | | | Details |
| 5/11/20 | |
Q120 | -$0.26 | -$0.22 | -$0.04 | $1.33M | $1.91M | N/A | | | Details |
| 3/14/18 | |
Q417 | -$0.24 | -$0.30 | +$0.06 | $8.8M | $7.53M | = | | | Details |
| 5/9/16 | Q116 | -$0.11 | -$0.14 | +$0.03 | $8.1M | $4.75M | N/A | | | Details | |
| 3/1/23 | Q422 | -$0.22 | -$0.17 | -$0.05 | $125K | $339.28K | N/A | | | Details |
